Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: The NELSON study

Thorax

Volumn 73, Issue 8, 2018, Pages

  Walter, Joan E ^a   Heuvelmans, Marjolein A ^a,b   De Bock, Geertruida H ^a   Yousaf Khan, Uraujh ^c   Groen, Harry J M ^a   Van Der Aalst, Carlijn M ^c   Nackaerts, Kristiaan ^d   Van Ooijen, Peter M A ^a   De Koning, Harry J ^c   Vliegenthart, Rozemarijn ^a   Oudkerk, Matthijs ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CENTRAL VOLUME OF DISTRIBUTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; LIMIT OF DETECTION; LUNG CANCER; LUNG LOBE; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TUMOR VOLUME; VISIBILITY; BELGIUM; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; EARLY CANCER DIAGNOSIS; INCIDENCE; LUNG TUMOR; MASS SCREENING; MIDDLE AGED; MULTIPLE PULMONARY NODULES; NETHERLANDS; PATHOLOGY; PROCEDURES; X-RAY COMPUTED TOMOGRAPHY;

AGED; BELGIUM; DIAGNOSIS, DIFFERENTIAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; MULTIPLE PULMONARY NODULES; NETHERLANDS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85049225314     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2017-211376     Document Type: Article

References (32)

1. Siegel RL, Miller KD, Jemal A, et al. Cancer statistics, 2017. CA Cancer J Clin 2017;67:7-30.
2. van der Aalst CM, Ten Haaf K, de Koning HJ. Lung cancer screening: Latest developments and unanswered questions. Lancet Respir Med 2016;4:749-61.
3. Smith RA, Andrews K, Brooks D, et al. Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2016;66:95-114.
4. Moyer VA. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330-338-8.
5. de Koning HJ, Meza R, Plevritis SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: A comparative modeling study for the U.S. Preventive services task force. Ann Intern Med 2014;160:311-20.
6. American College of Radiology. LungRADSTM Version 1.0 Assessment Categories Release date: April 28, 2014. https://www. acr. org/-/media/ACR/Files/RADS/Lung-RADS/LungRADS- AssessmentCategories. pdf? la= en (accessed Apr 2016).
7. Xu DM, Gietema H, de Koning H, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006;54:177-84.
8. Callister MEJ, Baldwin DR, Akram AR, et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules: Accredited by NICE. Thorax 2015;70:ii1-ii54.
9. MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: A statement from the Fleischner Society. Radiology 2005;237:395-400.
10. MacMahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: From the fleischner society 2017. Radiology 2017;284:161659-243.
11. Oudkerk M, Devaraj A, Vliegenthart R, et al. European position statement on lung cancer screening. Lancet Oncol 2017;18:e754-e766.
12. Henschke CI, Yankelevitz DF, Naidich DP, et al. CT screening for lung cancer: Suspiciousness of nodules according to size on baseline scans. Radiology 2004;231:164-8.
13. Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: A prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014;15:1332-41.
14. Walter JE, Heuvelmans MA, de Jong PA, et al. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: Analysis of data from the randomised, controlled NELSON trial. Lancet Oncol 2016;17:907-16.
15. Walter JE, Heuvelmans MA, Oudkerk M. Small pulmonary nodules in baseline and incidence screening rounds of low-dose CT lung cancer screening. Transl Lung Cancer Res 2017;6:42-51.
16. Pinsky PF, Gierada DS, Nath PH, et al. Lung Cancer Risk Associated With New Solid Nodules in the National Lung Screening Trial. Am J Roentgenol 2017;209:1009-14.
17. Schabath MB, Massion PP, Thompson ZJ, et al. Differences in patient outcomes of prevalence, interval, and screen-detected lung cancers in the CT arm of the national lung screening trial. PLoS One 2016;11:e0159880.
18. Heuvelmans MA, Oudkerk M, de Jong PA, et al. The impact of radiologists' expertise on screen results decisions in a CT lung cancer screening trial. Eur Radiol 2015;25:792-9.
19. Xu DM, van Klaveren RJ, de Bock GH, et al. Limited value of shape, margin and CT density in the discrimination between benign and malignant screen detected solid pulmonary nodules of the NELSON trial. Eur J Radiol 2008;68:347-52.
20. McWilliams A, Tammemagi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med Overseas Ed 2013;369:910-9.
21. Xu DM, van der Zaag-Loonen HJ, Oudkerk M, et al. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: Cancer risk during 1 year of follow-up. Radiology 2009;250:264-72.
22. Horeweg N, van der Aalst CM, Thunnissen E, et al. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med 2013;187:848-54.
23. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868-74.
24. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med Overseas Ed 2009;361:2221-9.
25. Yousaf-Khan U, van der Aalst C, de Jong PA, et al. Final screening round of the NELSON lung cancer screening trial: The effect of a 2.5-year screening interval. Thorax 2017;72:48-56.
26. Gurney JW. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory. Radiology 1993;186:405-13.
27. Zhao YR, Heuvelmans MA, Dorrius MD, et al. Features of resolving and nonresolving indeterminate pulmonary nodules at follow-up CT: The NELSON Study. Radiology 2014;270:872-9.
28. Yousaf-Khan U, van der Aalst C, de Jong PA, et al. Risk stratification based on screening history: The NELSON lung cancer screening study. Thorax 2017;72:819-24.
29. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988;44:837-45.
30. Vickers AJ, Cronin AM, Elkin EB, et al. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak 2008;8:53.
31. Steyerberg EW, Vergouwe Y. Towards better clinical prediction models: Seven steps for development and an ABCD for validation. Eur Heart J 2014;35:1925-31.
32. Bach PB, Mirkin JN, Oliver TK, et al. Benefits and Harms of CT Screening for Lung Cancer. JAMA 2012;307:2418.